Back

Empagliflozin significantly reduces circulating markers of endothelial dysfunction in Ischemia with Non-Obstructive Coronary Arteries (INOCA) and coronary microvascular dysfunction: a pilot trial

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular disease in women around the world Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Odayme Quesada

The Christ Hospital Health Network, Cincinnati (United States of America)

7 More presentations in this session

Presentation thumbnail
Sex differences in health status trajectories among Chinese patients with angina pectoris: insights from the GREAT registry study
Professor X. Du (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Sex disparities in ischaemic heart disease mortality in South Asia: a global burden of disease 2021 analysis
Ms T. Rahaman (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Impact of atorvastatin on serum oestradiol and estrone concentrations in postmenopausal women with chronic coronary artery disease: a randomized trial.
Miss N. Faria (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Coronary artery disease-related sudden cardiac arrest in women
Doctor O. Weizman (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Bridging the gender gap in TAVI: real-world evidence from a single-centre study
Doctor R. Batista Louro (Evora, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular disease in women around the world

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Empagliflozin significantly reduces the capacity of sera to induce endothelial dysfunction in Ischemia Non-Obstructive Coronary Arteries (INOCA): EMbArk phase II pilot trial
thumbnail
Congress Presentation
Twelve-months treatment with dapagliflozin improves endothelial glycocalyx and cardiovascular function in patients with type 1 diabetes mellitus
thumbnail
Congress Presentation
Evaluation of coronary microvascular dysfunction and vasospasm in patients with angina and non-obstructive coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources